Laboratory Information Systems (LIS): Page 3

CliniSys acquires Horizon Lab, combines with Sunquest

By LabPulse.com staff writers

Together, the companies have more than 1,300 employees in 12 countries. The companies said that the newly formed group will enable improved public health outcomes through innovation in diagnostics and laboratory informatics technology.

January 17, 2022

Pillar's NGS lab receives certification, state permit

By LabPulse.com staff writers

The Natick, MA-based lab also received the state permit. All of this means the lab can support preclinical studies and clinical trials, with the longer-term potential to provide companion diagnostics for the company's pharmaceutical partners.

January 9, 2022

ASH 2021: What technologies will disrupt hematology diagnostics?

By Leah Sherwood

Changing how clinicians approach medicine

December 10, 2021

Vivera debuts new testing software

By LabPulse.com staff writers

Featuring artificial intelligence (AI)-based identity verification, LabPort aims to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments. It can integrate with other laboratory information management systems so information can be shared seamlessly.

November 22, 2021

PathAI announces results showing reliability of NASH scoring

By LabPulse.com staff writers

Specifically, the study demonstrated that panel scoring can support the reproducibility of NASH scoring and reduce bias, as demonstrated in biopsies obtained in a phase III clinical trial, according to PathAI.

November 15, 2021

PathAI partners with Roche for AI tech

By LabPulse.com staff writers

The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.

October 14, 2021

Thermo Fisher gets FDA approval for lung cancer test

By LabPulse.com staff writers

The test will be used as a companion diagnostic to identify patients who are candidates for treatment with Exkivity (mobocertinib) from Takeda Pharmaceutical. The Oncomine Dx Target Test is intended to help identify patients who have epidermal growth factor receptor (EGFR) Exon20 insertion mutations.

September 16, 2021

Agilent enters digital pathology with Visiopharm deal

By LabPulse.com staff writers

Visiopharm's artificial intelligence-driven precision pathology software products have the CE Mark for in vitro diagnostic devices. The products are designed to improve diagnostic accuracy and workload management for pathologists, according to Agilent.

September 1, 2021

Thermo Fisher, AstraZeneca to develop NGS companion diagnostics

By LabPulse.com staff writers

Their multiyear, global deal will help support AstraZeneca's therapy portfolio. Over 90% of AstraZeneca's clinical pipeline is targeted precision medicine therapies covering a range of therapeutic areas.

August 31, 2021

PreciseMDX launches lab connectivity software

By LabPulse.com staff writers

PreciseMDX allows labs to establish personalized digital portals for both providers and patients. It handles a variety of tasks, from scheduling and check-in, to planning onsite or home testing, to delivering test results, the company said.

August 29, 2021

AI can lend a hand in diagnosis, prognosis of oral SCC

By Erik L. Ridley

After reviewing published studies in the literature on the use of AI with pathology and radiology images in patients with oral SCC, researchers from the University of Hong Kong concluded that the technology yielded good classification accuracy.

August 18, 2021

Tempus seeks FDA premarket approval for xT-Onco assay

By LabPulse.com staff writers

In addition to premarket approval, the submission includes companion diagnostic claims, tumor profiling claims, and microsatellite instability status, using DNA isolated from formalin-fixed paraffin embedded tumor tissue specimens and matched normal specimens.

August 17, 2021

Previous Page

Page 3 of 16

Next Page